In parallel, pathway enrichment showed that WARS1 expression was related to enhanced immune-cell infiltration, activation of the cancer immunity cycle, and upregulation of cell-cycle and DNA-repair pathways, together with stromal programs including EMT and angiogenesis. This evidence concerns the gene WARS1 and cancer.